# Original number of entities in query: 11095,,,,,,,# Number of entities in query: 11094,,,,,,,# Total number of entities: 11094,,,,,,,# Total number of attributes: 2073,,,,,,,# Translation required: no,,,,,,,# Mode: ordered,,,,,,,# Number of simulations: 1000,,,,,,,# Adjusted P-value cutoff: 0.05,,,,,,,# Over/under: over,,,,,,,OVERREPRESENTED ATTRIBUTES,,,,,,,N,M,X,LOD,P,P_adj,attrib ID,attrib name14,357,30,1.438212867,9.05E-14,0,MaxNala696,collagen fibril organization17,873,29,1.222405142,3.08E-12,0,MaxNala1584,sprouting angiogenesis17,1589,24,1.149041158,5.28E-10,0,MaxNala382,regulation of pathway-restricted SMAD protein phosphorylation86,7195,89,1.131783685,3.02E-13,0,MaxNala1962,SRP-dependent cotranslational protein targeting to membrane13,1374,21,1.054228229,1.19E-07,0.007,MaxNala580,keratan sulfate biosynthetic process10,310,47,1.000621009,5.20E-07,0.025,MaxNala1777,artery development16,1244,29,0.99065976,9.31E-09,0.002,MaxNala1522,complement activation12,913,26,0.987790461,2.93E-07,0.019,MaxNala1706,negative regulation of BMP signaling pathway16,646,46,0.95130421,2.80E-09,0.001,MaxNala417,positive regulation of endothelial cell proliferation14,1396,25,0.946216737,2.70E-07,0.018,MaxNala49,keratan sulfate metabolic process16,675,45,0.945083575,3.64E-09,0.001,MaxNala17,regulation of leukocyte chemotaxis19,597,60,0.929069493,1.49E-10,0,MaxNala1873,positive regulation of chemotaxis22,1244,43,0.925026617,1.07E-10,0,MaxNala1916,protein activation cascade50,662,152,0.919582762,1.52E-24,0,MaxNala695,extracellular matrix organization50,662,153,0.915324235,2.13E-24,0,MaxNala503,extracellular structure organization26,675,77,0.914575421,1.86E-13,0,MaxNala1849,regulation of chemotaxis13,1302,25,0.913363466,1.01E-06,0.048,MaxNala921,regulation of smooth muscle cell migration16,1267,32,0.894304554,7.70E-08,0.006,MaxNala955,regulation of protein processing20,646,63,0.893606482,1.90E-10,0,MaxNala802,regulation of endothelial cell proliferation13,675,40,0.886535225,3.64E-07,0.022,MaxNala1106,positive regulation of leukocyte chemotaxis77,7314,82,0.866324911,1.50E-09,0.001,MaxNala224,translational elongation20,597,70,0.865922874,3.90E-10,0,MaxNala925,positive regulation of behavior12,226,98,0.861186076,6.62E-07,0.031,MaxNala569,cardiac chamber development19,2938,26,0.860795832,9.15E-07,0.045,MaxNala789,negative regulation of cell-substrate adhesion16,1630,29,0.854612865,4.44E-07,0.024,MaxNala192,smooth muscle cell differentiation18,1520,35,0.827663506,1.17E-07,0.007,MaxNala1101,regulation of epithelial to mesenchymal transition81,6030,91,0.819166042,8.79E-13,0,MaxNala452,establishment of protein localization to endoplasmic reticulum81,6030,91,0.819166042,8.79E-13,0,MaxNala1958,cotranslational protein targeting to membrane62,5897,70,0.815508535,2.19E-10,0,MaxNala978,viral transcription & viral genome expression80,6030,90,0.813731323,1.45E-12,0,MaxNala471,protein targeting to ER15,938,41,0.807279805,5.61E-07,0.027,MaxNala1149,artery morphogenesis17,597,67,0.794956826,5.75E-08,0.006,MaxNala20,regulation of leukocyte migration23,454,117,0.783763611,2.73E-10,0,MaxNala1432,negative regulation of locomotion15,349,97,0.777381401,3.22E-07,0.021,MaxNala1098,positive regulation of cell adhesion21,662,80,0.766650145,5.13E-09,0.001,MaxNala791,regulation of cell-substrate adhesion19,1113,49,0.764407553,9.15E-08,0.006,MaxNala1709,regulation of BMP signaling pathway29,606,122,0.754303799,9.95E-12,0,MaxNala641,positive regulation of response to external stimulus23,586,101,0.743609413,1.82E-09,0.001,MaxNala70,negative regulation of cell migration27,675,107,0.736126371,1.37E-10,0,MaxNala306,regulation of behavior31,1374,73,0.727492007,1.14E-10,0,MaxNala1937,aminoglycan biosynthetic process & glycosaminoglycan biosynthetic process23,586,104,0.727196532,3.35E-09,0.001,MaxNala707,negative regulation of cell motility25,924,79,0.721172796,2.39E-09,0.001,MaxNala761,positive regulation of angiogenesis87,6030,101,0.709932159,8.21E-12,0,MaxNala1747,protein localization to endoplasmic reticulum23,586,108,0.706221398,7.26E-09,0.001,MaxNala1086,negative regulation of cellular component movement23,1030,70,0.691888549,3.60E-08,0.006,MaxNala1205,positive regulation of ERK1 and ERK2 cascade50,807,189,0.685736389,3.08E-16,0,MaxNala1433,positive regulation of locomotion62,5708,74,0.677528739,5.40E-09,0.001,MaxNala223,translational termination22,1043,68,0.675729991,1.22E-07,0.007,MaxNala1197,negative regulation of cellular response to growth factor stimulus49,807,189,0.67333235,1.48E-15,0,MaxNala1087,positive regulation of cellular component movement52,938,179,0.668249661,5.75E-16,0,MaxNala1531,positive regulation of cell migration41,1396,104,0.667049105,3.71E-12,0,MaxNala1471,glycosaminoglycan metabolic process24,1756,52,0.664620986,2.43E-07,0.016,MaxNala59,positive regulation of transmembrane receptor protein serine/threonine kinase signaling pathway53,938,184,0.663345505,4.48E-16,0,MaxNala708,positive regulation of cell motility27,713,117,0.658522251,3.93E-09,0.001,MaxNala1193,regulation of cellular response to growth factor stimulus42,1396,109,0.651000077,4.96E-12,0,MaxNala1936,aminoglycan metabolic process21,913,75,0.650935985,3.83E-07,0.022,MaxNala58,negative regulation of transmembrane receptor protein serine/threonine kinase signaling pathway30,2012,61,0.645496645,3.08E-08,0.006,MaxNala509,regulation of endothelial cell migration32,1129,98,0.644270447,9.84E-10,0.001,MaxNala38,positive regulation of epithelial cell proliferation26,767,109,0.64193901,1.65E-08,0.003,MaxNala634,mesenchyme development23,1592,55,0.63979609,6.28E-07,0.03,MaxNala1244,regulation of biomineral tissue development21,526,123,0.637794912,2.82E-07,0.018,MaxNala108,inner ear development80,6513,93,0.626788436,9.39E-09,0.002,MaxNala981,carbohydrate biosynthetic process26,1229,77,0.62286073,9.47E-08,0.006,MaxNala1611,bone development36,1770,83,0.613855914,2.58E-09,0.001,MaxNala1682,cell chemotaxis32,646,165,0.611370491,1.27E-09,0.001,MaxNala39,regulation of epithelial cell proliferation35,785,153,0.609397415,3.54E-10,0,MaxNala1614,ossification23,1098,76,0.608642944,6.27E-07,0.03,MaxNala1467,ureteric bud development28,1400,77,0.607052053,8.19E-08,0.006,MaxNala145,cardiocyte differentiation36,1623,90,0.599118257,3.30E-09,0.001,MaxNala1952,sulfur compound biosynthetic process32,1466,87,0.591960567,2.20E-08,0.004,MaxNala1236,regulation of striated muscle tissue development & regulation of muscle tissue development32,1466,88,0.584159736,3.02E-08,0.006,MaxNala390,regulation of muscle organ development93,6818,108,0.582317828,1.36E-08,0.002,MaxNala226,translational initiation26,1591,68,0.576163866,9.45E-07,0.045,MaxNala1518,humoral immune response33,924,133,0.575808432,7.53E-09,0.001,MaxNala213,regulation of angiogenesis30,1218,97,0.571643752,7.74E-08,0.006,MaxNala1660,cell-substrate adhesion27,1770,66,0.569118941,1.03E-06,0.049,MaxNala1400,leukocyte chemotaxis30,913,126,0.557263406,7.52E-08,0.006,MaxNala1828,regulation of transmembrane receptor protein serine/threonine kinase signaling pathway29,1400,86,0.55692275,3.16E-07,0.021,MaxNala270,gland morphogenesis102,6035,126,0.550289435,3.12E-10,0,MaxNala1959,protein targeting to membrane33,633,197,0.543097694,1.97E-08,0.003,MaxNala1018,response to alcohol67,5708,85,0.540590409,1.56E-07,0.011,MaxNala1890,cellular protein complex disassembly79,5897,99,0.537922337,2.81E-08,0.006,MaxNala415,viral infectious cycle36,1161,128,0.537866929,1.80E-08,0.003,MaxNala215,skeletal system morphogenesis68,5708,87,0.52411041,2.29E-07,0.014,MaxNala1534,protein complex disassembly52,1666,143,0.520930775,2.05E-10,0,MaxNala1282,regulation of vasculature development44,1410,138,0.519159816,2.77E-09,0.001,MaxNala1927,morphogenesis of a branching epithelium30,898,138,0.513926877,4.41E-07,0.024,MaxNala948,respiratory system development45,1410,144,0.506511383,3.74E-09,0.001,MaxNala67,morphogenesis of a branching structure38,1468,119,0.498613941,9.37E-08,0.006,MaxNala1903,branching morphogenesis of an epithelial tube30,653,190,0.496044825,6.44E-07,0.031,MaxNala1153,cellular divalent inorganic cation homeostasis70,5708,91,0.494197272,4.65E-07,0.024,MaxNala1350,nuclear-transcribed mRNA catabolic process41,1379,137,0.490054907,3.83E-08,0.006,MaxNala1394,negative regulation of peptidase activity36,1646,106,0.479276401,6.35E-07,0.031,MaxNala890,cartilage development44,1646,130,0.477937696,4.17E-08,0.006,MaxNala1845,connective tissue development39,1379,134,0.47252455,1.86E-07,0.014,MaxNala502,negative regulation of endopeptidase activity52,1322,188,0.464971308,2.77E-09,0.001,MaxNala1472,renal system development47,1806,132,0.46329124,4.57E-08,0.006,MaxNala1528,regulation of ossification48,1440,163,0.458890163,1.96E-08,0.003,MaxNala1953,leukocyte migration58,3195,110,0.445144153,1.04E-07,0.007,MaxNala1751,cellular carbohydrate metabolic process55,1623,176,0.435067017,1.32E-08,0.002,MaxNala7,sulfur compound metabolic process58,2822,125,0.410340549,2.85E-07,0.018,MaxNala1072,lung development44,1264,181,0.410000144,6.85E-07,0.033,MaxNala504,activation of immune response59,2822,128,0.405071875,2.99E-07,0.02,MaxNala1070,respiratory tube development